Heron Therapeutics Q3 Earnings Preview
What it means
- What to watch: The earnings call often says more than the earnings — tone on demand, costs and the next quarter is the thing to hear.
- How the stock is trading: $HRTX +5.32% in the latest session.
- Timing: It dropped mid-session, while New York was open, so the move beside it may already include the market's first reaction.
Where the stock stands
$HRTX last changed hands at $0.29, +5.32% on the session, 81% below its 52-week high of $1.58 and 13% above its low of $0.26 — within a tenth of its 52-week low. Over the year it has ranged 508% from low to high: a very wide band; big swings are routine for this one, not news. These are latest-session quotes, not live prices — the live tape is on the $HRTX page.
How much coverage it is getting
Nothing else on $HRTX in the last 30 days: this is the only story Wook has filed, so there is no run to measure it against yet. 12 related stories — same name or same desk — are lined up beside this one if you want the whole thread.
The bigger picture
With earnings, the number matters less than the number versus expectations — and guidance often matters more than both. A beat paired with a soft outlook can still get a cold reception. On Wook's supply-chain scanner, Health Care reads watch today — early signs of strain worth keeping an eye on.
Coming up
$HRTX earnings in 3 days. These were on the calendar before this story and are not caused by it, but the nearest is close enough that the hard numbers get the last word soon.
What to watch next
For the receipts, the $HRTX page has the full chart, the filings and the valuation model these figures come from. Because one outlet dominates the coverage, reading another outlet on the same story is the quickest check on whether it is being confirmed or just repeated. Wook AI, above, can pull live figures and run the numbers on request — how far $HRTX is from its high, or how this week's coverage compares.
How this analysis was made
Seeking Alpha published it, and Wook filed it under Earnings. No strongly worded term either way, so it reads neutral at low severity — a factual headline rather than a charged one. It was matched to $HRTX. The publisher gave no preview text, and nothing has been written in to fill the gap.
The tone and severity labels come from a fixed word list — no editor, no AI, no crystal ball — so they describe how a story is worded, not what happens next. They are not a forecast or a recommendation, and a same-day move does not mean this story caused it. Not investment advice.
Discussion
No one has weighed in yet. Start the discussion on this story.
What happened after this published
Seeking Alpha published this on November 6, 2026. $HRTX has moved +1.72% ($0.29 to $0.29). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.